Please confirm you are human (Sign Up for free to never see this)
← Back to Search
P53 Mutations In Human Cancers.
M. Hollstein, D. Sidransky, B. Vogelstein, C. Harris
Published 1991 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Mutations in the evolutionarily conserved codons of the p53 tumor suppressor gene are common in diverse types of human cancer. The p53 mutational spectrum differs among cancers of the colon, lung, esophagus, breast, liver, brain, reticuloendothelial tissues, and hemopoietic tissues. Analysis of these mutations can provide clues to the etiology of these diverse tumors and to the function of specific regions of p53. Transitions predominate in colon, brain, and lymphoid malignancies, whereas G:C to T:A transversions are the most frequent substitutions observed in cancers of the lung and liver. Mutations at A:T base pairs are seen more frequently in esophageal carcinomas than in other solid tumors. Most transitions in colorectal carcinomas, brain tumors, leukemias, and lymphomas are at CpG dinucleotide mutational hot spots. G to T transversions in lung, breast, and esophageal carcinomas are dispersed among numerous codons. In liver tumors in persons from geographic areas in which both aflatoxin B1 and hepatitis B virus are cancer risk factors, most mutations are at one nucleotide pair of codon 249. These differences may reflect the etiological contributions of both exogenous and endogenous factors to human carcinogenesis.
This paper references
Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair.
C. Harris (1989)
Detecting mutations in human genes.
J. Marx (1989)
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
B. Bressac (1991)
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.
S. Baker (1989)
Frequent mutation of the p53 gene in human esophageal cancer.
M. Hollstein (1990)
Mutagenesis by apurinic/apyrimidinic sites.
L. Loeb (1986)
Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene
I. Mellon (1987)
Aflatoxin-albumin adducts in human sera from different regions of the world.
C. Wild (1990)
Sequence specificity in aflatoxin B1--DNA interactions.
K. Muench (1983)
The effect of the pyrrolizidine alkaloid integerrimine on the chromosomes of mouse bone marrow cells.
M. C. Gimmler-Luz (1990)
Endogenous genotoxic agents and processes as a basis of spontaneous carcinogenesis.
W. Lutz (1990)
Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.
P. Hinds (1989)
Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line.
Joseph W. Romano (1989)
Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors.
G. Mcmahon (1990)
p53: a frequent target for genetic abnormalities in lung cancer.
T. Takahashi (1989)
Spectrum of spontaneous mutation at the APRT locus of Chinese hamster ovary cells: an analysis at the DNA sequence level.
P. D. de Jong (1988)
p53 functions as a cell cycle control protein in osteosarcomas.
L. Diller (1990)
Preferential DNA repair in expressed genes.
P. Hanawalt (1987)
Association of human papillomavirus types 16 and 18 E6 proteins with p53.
B. Werness (1990)
Wild-type p53 can inhibit oncogene-mediated focus formation.
D. Eliyahu (1989)
Increased cell division as a cause of human cancer.
S. Preston-Martin (1990)
Spontaneous deamination of cytosine and 5-methylcytosine residues in DNA and replacement of 5-methylcytosine residues with cytosine residues.
M. Ehrlich (1990)
Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
Jane Prosser (1990)
Rearrangement of the p53 gene in human osteogenic sarcomas.
H. Masuda (1987)
Frequency and structure of p53 rearrangements in human osteosarcoma.
C. Miller (1990)
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.
I. Chiba (1990)
Mechanisms of p53 loss in human sarcomas.
L. Mulligan (1990)
Mechanistic studies of ionizing radiation and oxidative mutagenesis: genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genome.
M. Wood (1990)
p53 mutations in colorectal cancer.
N. Rodrigues (1990)
Specific interaction between the p53 cellular tumour antigen and major heat shock proteins
O. Pinhasi-Kimhi (1986)
Human pulmonary alveolar macrophages metabolise benzo(a)pyrene to proximate and ultimate mutagens
C. Harris (1978)
A deadly inheritance
B. Vogelstein (1990)
Sequence specificity of mutations induced by benzo[a]pyrene-7,8-diol-9,10-epoxide at endogenousaprt gene in CHO cells
M. Mazur (1988)
Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines.
J. Cheng (1990)
5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes.
W. Rideout (1990)
Oxidative damage to DNA: relation to species metabolic rate and life span.
R. Adelman (1988)
Effect of excision repair by diploid human fibroblasts on the kinds and locations of mutations induced by (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene in the coding region of the HPRT gene.
R. Chen (1990)
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.
S. Baker (1990)
Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
D. Linzer (1979)
Mutational specificity in bacteria.
J. H. Miller (1983)
Presence of a potent transcription activating sequence in the p53 protein.
S. Fields (1990)
Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage.
M. Shigenaga (1989)
Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.
D. Wolf (1985)
Chemical carcinogenesis: too many rodent carcinogens.
B. Ames (1990)
Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse.
M. You (1989)
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.
B. Bressac (1990)
Oncogene activation in chemical carcinogenesis.
A. Balmain (1988)
Suppression of human colorectal carcinoma cell growth by wild-type p53.
S. Baker (1990)
Mutational specificity of alkylating agents and the influence of DNA repair
M. J. Horsfall (1990)
T antigen is bound to a host protein in SY40-transformed cells
D. Lane (1979)
Heterogeneous DNA damage and repair in the mammalian genome.
V. Bohr (1987)
Base substitution mutations induced by metabolically activated aflatoxin B1.
P. Foster (1983)
The search for the causes of breast and colon cancer
W. Willett (1989)
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome
S. Srivastava (1990)
Identification of p53 as a sequence-specific DNA-binding protein
S. Kern (1991)
Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells
P. Sarnow (1982)
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
D. Malkin (1990)
Mutational spectrometry in animal toxicity testing.
W. Thilly (1990)
Increased expression of mutant forms of p53 oncogene in primary lung cancer
R. Iggo (1990)
Markers of exposure to carcinogens.
G. Wogan (1989)
Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.
A. Menon (1990)
Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 T antigen.
J. Jenkins (1988)
Mutations in the p53 gene occur in diverse human tumour types
J. Nigro (1989)
5-Methylcytosine in eukaryotic DNA.
M. Ehrlich (1981)
Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.
H. Ahuja (1989)
Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: The role of dna base damage
L. Breimer (1990)
Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG
S. Shibutani (1991)
Mismatch-specific thymine DNA glycosylase and DNA polymerase beta mediate the correction of G.T mispairs in nuclear extracts from human cells.
K. Wiebauer (1990)
The p53 proto-oncogene can act as a suppressor of transformation
C. Finlay (1989)
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
I. C. Hsu (1991)
Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.
W. Mercer (1990)
This paper is referenced by
Multiple Signal Pathways Involved in Crocetin-Induced Apoptosis in KYSE-150 Cells
S. Li (2019)
Current Progress in Covalent Modification of Biomolecules by Compounds in Food or Oxidatively Generated Compounds Its Relevance to Biological Functions
Y. Kawai (2017)
Identification of a p53-dependent negative response element in the bcl-2 gene.
T. Miyashita (1994)
The silence of p66(Shc) in HCT8 cells inhibits the viability via PI3K/AKT/Mdm-2/p53 signaling pathway.
L. Zhang (2015)
P53 Inducible Gene-3: Potential Serum Marker for Hepatocellular Carcinoma Beyond Milan Criteria
M. Bhat (2015)
Targeting nucleocytoplasmic transport in cancer therapy
R. Hill (2014)
Breast Cancer Gene Therapy
G. Büyükköroğlu (2014)
p53 mediated apoptosis by reduction sensitive shielding ternary complexes based on disulfide linked PEI ternary complexes.
Yiyan He (2014)
Depression of p53-independent Akt survival signals in human oral cancer cells bearing mutated p53 gene after exposure to high-LET radiation.
Y. Nakagawa (2012)
Centrosomal Protein 55 (Cep55) Stability Is Negatively Regulated by p53 Protein through Polo-like Kinase 1 (Plk1)*
Y. Chang (2011)
Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice as an Animal Model of Spontaneous Uterine Leiomyosarcoma
T. Hayashi (2011)
Inferring the Association Network from p53 Sequence Alignment Using Granular Evaluations
D. Chiu (2013)
MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma
L. Jin (2011)
MUTYH DNA glycosylase: the rationale for removing undamaged bases from the DNA
Enni Markkanen (2013)
Human hepatocyte carcinogenesis
H. Shiraha (2013)
PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis
I. Rybanská (2013)
The Association Between TP53 Arg72Pro Polymorphism and Lung Cancer Susceptibility: Evidence from 30,038 Subjects
Qian Qiao (2013)
Aldo-keto reductases protect lung adenocarcinoma cells from the acute toxicity of B[a]P-7,8-trans-dihydrodiol.
Z. Abedin (2012)
Malignant Transformation of Melanocytic Nevi
Alexander Marzuka-Alcalá (2012)
Patient with multiple primary carcinomas including 4 separate oral cancers: study of p53 mutations and their implications for management.
M. Fukuda (2006)
Animal Experimentation: Working Towards a Paradigm Change
K. Herrmann (2019)
Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer.
F. Faraji (2017)
Wild-type and cancer-related p53 proteins are preferentially degraded by MDM2 as dimers rather than tetramers.
C. Katz (2018)
Clinical effects of p53 overexpression in squamous cell carcinoma of the sinonasal tract
X. Wang (2017)
Gene mutations in Cushing's disease.
Q. Xiong (2016)
Identification of a novel feline large granular lymphoma cell line (S87) as non-MHC-restricted cytotoxic T-cell line and assessment of its genetic instability.
L. Rydzewski (2016)
Molecular and genetic mechanisms of lymphomagenesis.
R. Kušec (2002)
Selective killing of human breast cancer cells by the styryl lactone (R)-goniothalamin is mediated by glutathione conjugation, induction of oxidative stress and marked reactivation of the R175H mutant p53 protein
S. Punganuru (2018)
Alterations of tumour protein 53 (TP53) pathways in diffuse large B-cell lymphomas
Dalia Magdi Abdel-Azim (2009)
The mechanisms of cellular sensitivity to photodynamic therapy
Z. Tong (2002)
Understanding the role of Merkel cell polyomavirus oncoproteins in the cellular transformation of mammalian Merkel cells
L. M. Knight (2014)
Efficient Modulation of TP53 Expression in Human Induced Pluripotent Stem Cells.
Constanze Uhlmann (2020)See more